KARD

Kardigan, Inc.

Nasdaq· CIK 0002123613

$12.80 +0.06 (+0.47%)

Oct 23 4:00 PM ET · prev $12.74

Market cap

$1.2B

Small cap

Consensus

Buy

90% Buy or better · 10 analysts

Median target

$41.50

+224% · range $25.00–46.00

Since first trade

−41.8%

from $22.00 · Jun 18

30 days

−13.4%

from $14.78

Range since listing

$12.74–25.90

−51% from high · low Oct 22

Avg volume 20D

639.4K

shares / day

Short interest

🔒 Subscribers only

Insider net

+$90.0M

3 buyers · 0 sellers · 12 mo

New fund stakes

Q2 2026 13F · 0 exits

Filing reports

analyzed by SecBot

SecBot read MIXED 3 reports · 90 days

Balance 0 bearish · 0 bullish · 3 neutral oldest → newest, height = score

Avg score

·High conf. 3/3

Strongest NEUTRAL Perceptive Advisors filed an amended Schedule 13D disclosing that its Managing Director, Douglas Giordano…

All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

R Jun 18 Kardigan, Inc.'s S-1 registration statement (File No. 333-296236) fo…
B Jun 22 3 insiders buy $90.0M at $16.00
R Jun 25 Three insiders at Kardigan, including directors and 10% owners, coll…
I Jun 30 8 funds open new positions (13F)
A Jul 13 4 analysts initiate
X Sep 30 Short interest jumps 73.0% to 4.45M
A Oct 16 William Blair initiates
A Oct 22 Baird initiates

Signal stack

Where each data set points today.

InsidersBULLISH

3 insiders bought $90.0M at an average $16.00. No open-market sales. Price is 20% below their cost.
InstitutionsBULLISH

Q2 2026: 8 added (8 new), 0 trimmed or exited. Largest new: Fmr $212.5M, Capital Research Global Investors $85.8M.
AnalystsBULLISH

9 of 10 rate it Buy or better. Every target is above the price.
TrendDOWNTREND

25% below its 50-day average. New closing low $12.74 on Oct 22.

Who's buying

13F· Q2 2026

new positions

exits

$449.5M

in new stakes

Fund	Move	Shares	Value
FMR LLC	NEW	8,909,066	$212.5M
Capital Research Global Investors	NEW	3,598,942	$85.8M
JPMORGAN CHASE & CO	NEW	1,790,734	$46.4M
ALLIANCEBERNSTEIN L.P.	NEW	1,534,837	$36.6M
JENNISON ASSOCIATES LLC	NEW	903,575	$21.6M
PRICE T ROWE ASSOCIATES INC /MD/	NEW	658,787	$15.7M
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	NEW	650,000	$15.5M
GOLDMAN SACHS GROUP INC	NEW	644,969	$15.4M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

10 analysts

Buy 90% rate it Buy or better

Strong Buy4Buy5Hold1Sell0Strong Sell0

12-month targets · 6 analysts

$12.80 $25.00 $41.50 $46.00

Price is below the lowest target. Median implies +224%.Targets as of Oct 27, 2026.

Recent actions

Date	Firm	Action	Rating
Oct 22, 2026	Baird INITIATE	INITIATE	Outperform
Oct 16, 2026	William Blair INITIATE	INITIATE	Outperform
Oct 12, 2026	UBS INITIATE	INITIATE	Buy
Aug 25, 2026	JP Morgan MAINTAIN	MAINTAIN	Overweight
Jul 13, 2026	TD Cowen INITIATE	INITIATE	Buy
Jul 13, 2026	Leerink Partners INITIATE	INITIATE	Outperform

Insider ledger

Form 4

$90.0M

bought · 3 insiders

sold · 0 insiders

−20.0%

vs their $16.00 cost

Date	Insider	Type	Value
Sep 29, 2026	Reinke Kristin Marie K Director	AWARD	48,368 sh
Jun 22, 2026	ARCH Venture Partners XIII, LLC Director	BUY	$20.0M
Jun 22, 2026	BERNS PAUL L Director	BUY	$20.0M
Jun 22, 2026	HRTG GPE, LLC 10%+ Owner	BUY	$50.0M
Jun 17, 2026	PERCEPTIVE ADVISORS LLC Director	AWARD	20,706 sh
Jun 17, 2026	Edelberg Jay Chief Medical Officer	CONVERT	97,587 sh
Jun 17, 2026	Edelberg Jay Chief Medical Officer	AWARD	47,784 sh
Jun 17, 2026	Edelberg Jay Chief Medical Officer	CONVERT	61,268 sh

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

Period	EPS est.	Range	30D rev.	Revenue
Current Q	🔒 Fresh data, subscribers only
Next Q	🔒 Fresh data, subscribers only
Current FY	🔒 Fresh data, subscribers only
Next FY	🔒 Fresh data, subscribers only